EPA:VIRP • FR0000031577
The current stock price of VIRP.PA is 343.5 EUR. Today VIRP.PA is down by -0.15%. In the past month the price decreased by -3.92%. In the past year, price increased by 16.05%.
ChartMill assigns a technical rating of 1 / 10 to VIRP.PA. When comparing the yearly performance of all stocks, VIRP.PA turns out to be only a medium performer in the overall market: it outperformed 66.21% of all stocks.
ChartMill assigns a fundamental rating of 5 / 10 to VIRP.PA. VIRP.PA has an average financial health and profitability rating.
16 analysts have analysed VIRP.PA and the average price target is 415.03 EUR. This implies a price increase of 20.82% is expected in the next year compared to the current price of 343.5.
For the next year, analysts expect an EPS growth of 3.73% and a revenue growth 4.9% for VIRP.PA
Over the last trailing twelve months VIRP.PA reported a non-GAAP Earnings per Share(EPS) of 17.34. The EPS increased by 20.61% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 10.4% | ||
| ROA | 8% | ||
| ROE | 13.64% | ||
| Debt/Equity | 0.22 |
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| 1SAN | SANOFI | 8.96 | 183.392B | ||
| SAN | SANOFI | 9 | 183.103B | ||
| SNW | SANOFI | 8.94 | 183.103B | ||
| UCB | UCB SA | 25.6 | 49.872B | ||
| UNC | UCB SA | 24.23 | 48.472B | ||
| 1MRK | MERCK KGAA | 12.53 | 46.826B | ||
| MRK | MERCK KGAA | 13.43 | 46.804B | ||
| BAYN | BAYER AG-REG | 8.47 | 36.929B | ||
| 1BAYN | BAYER AG-REG | 8.03 | 36.914B | ||
| IPN | IPSEN | 12.88 | 12.923B | ||
| REC | RECORDATI INDUSTRIA CHIMICA | 16.57 | 9.825B | ||
| TUB | FINANCIERE DE TUBIZE | N/A | 9.703B |
View all stocks in the Pharmaceuticals Industry | View all stocks in the Health Care Sector | View all stocks on the Euronext Paris Exchange | Find stocks with similar TA and Setup ratings on the EuroNext exchanges | Find stocks with similar Fundamental rating on the EuroNext exchanges | Find the competitors with the best technical ratings on the EuroNext exchanges | Find the competitors with the best fundamentals on the EuroNext exchanges | Find the competitors with the best valuation on the EuroNext exchanges | Find the competitors with the best dividend on the EuroNext exchanges | Find the competitors with the best analyst ratings on the EuroNext exchanges
Virbac SA engages in the manufacture and sale of veterinary medicines. The company is headquartered in Carros, Paca. Its production centers are located in France, Australia, the United States, Mexico, Vietnam, Brazil and South Africa. Its development efforts focus mainly on formulating drugs designed to prevent or cure certain animal diseases. Its product portfolio encompasses pet medications such as pest control drugs, vaccines, antibiotics, anesthetics, anti-inflammatory drugs, mouth/dental care products, ophthalmologic and dermatological products intended for dogs, cats, horses, birds and rodents, as well as livestock medications including pest control drugs and antibiotics intended for cattle, sheep, pigs and poultry. The company also offers food and electronic identification chips for pets.
IPO: 1985-01-01
VIRBAC SA
13e rue LID - BP 27
Carros PACA FR
Employees: 6365
Phone: 33492087100
Virbac SA engages in the manufacture and sale of veterinary medicines. The company is headquartered in Carros, Paca. Its production centers are located in France, Australia, the United States, Mexico, Vietnam, Brazil and South Africa. Its development efforts focus mainly on formulating drugs designed to prevent or cure certain animal diseases. Its product portfolio encompasses pet medications such as pest control drugs, vaccines, antibiotics, anesthetics, anti-inflammatory drugs, mouth/dental care products, ophthalmologic and dermatological products intended for dogs, cats, horses, birds and rodents, as well as livestock medications including pest control drugs and antibiotics intended for cattle, sheep, pigs and poultry. The company also offers food and electronic identification chips for pets.
The current stock price of VIRP.PA is 343.5 EUR. The price decreased by -0.15% in the last trading session.
VIRBAC SA (VIRP.PA) has a dividend yield of 0.41%. The yearly dividend amount is currently 1.32.
VIRP.PA has a ChartMill Technical rating of 1 out of 10 and a ChartMill Fundamental rating of 5 out of 10.
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on VIRP.PA.
The Revenue of VIRBAC SA (VIRP.PA) is expected to grow by 4.9% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.
VIRBAC SA (VIRP.PA) currently has 6365 employees.